OCULAR MANIFESTATIONS OF VIRAL INFECTIONS IN CHILDREN
https://doi.org/10.22627/2072-8107-2016-15-3-57-62
Abstract
In case of viral infections, ophthalmologists, pediatricians and general practitioners should all be aware of ocular manifestations of these diseases. According to our observations, despite the presence of corneal disorders, in 95 percent of children changes were reversible and in 1.5 months visual acuity was high. Only in five percent of cases despite the intensive therapy, patients had bacterial complications, causing a decrease in visual acuity.
The combined efforts of infectious disease specialists and ophthalmologists as well as timely and proper treatment are required to reduce the inflammation symptoms and prevent complications. By adding Ophtalmoferon® medication to the complex therapy of ocular surface diseases we observed its high therapeutic efficacy and a good safety profile. This medication is available in the form of ready-to-use eye drops, unlike other antiviral agents, improving its compliance in outpatients.
About the Authors
E. Yu. Markovа
N.I. Pirogov Russian National Research Medical University; Moscow Children's Health Clinic №12 , Moscow
Russian Federation
Russian Federation
Markova Elena — Dr Med. Sci, professor of department of ophthalmology.
117997, Moscow, ul. Ostrovityanova, 1, markova_ej@mail.ruN. A. Pron'ko
Moscow Children's Health Clinic №12 , Moscow
Russian Federation
Russian Federation
L. V. Venediktovа
Moscow Children's Health Clinic №12 , Moscow
Russian Federation
Russian Federation
References
1. Shamsheva O.V., Molochkova O.V. [The Range of Application of Domestic Antiviral Medication in Pediatrics] // Children Infections, 2015;14(4):26—30. (In Russ.)
2. Astakhov Yu.S., Sokolov V.O., Morozova N.V. [The tolerability and clinical efficacy of Okomistin in combination with Ophtalmoferon in the treatment of adenoviral eye diseases]. // Ophthalmology Journal (Ophthalmologic Vedomosti) 2013;VI(4):51—55. (In Russ.)
3. Neroev V.V., Maychuk Yu.F. [The diseases of conjunctiva. Short edition of the National Manual of Ophthalmology]. — Moscow, 2014; Ch8:367—407. (In Russ.)
4. Astakhov Yu.S., Riks I.A. [Modern methods of diagnosis and treatment of conjunctivitis: Methodological Guide]. — St. Petersburg, 2007;12—14. (In Russ.)
5. Pediatrics. National Manual]. Short Edition, edited by Baranov A.A., — Moscow, 2013;Ch.54: Conjunctivitis and keratitis in children:735—749. (In Russ.)
6. Brzheskiy V.V., Kalinin I.V. [Key areas of medication-based therapy in patients with corneoconjunctival xerosis] // Meditsinsky Sovet (Medical Council) 2015;(11):120—125. (In Russ.)
7. Aznabaev M.T., Malkhanov V.B. [Adenoviral and chlamydial eye diseases]. — Ufa, 1995;110. (In Russ.)
8. Kaneko H., Suzutani T., Aoki K. et al. Epidemiological and virological features of epidemic keratoconjunctivitis due to new human adenovirus type 54 in Japan // Br J Ophthalmol. 2011. № 95(1). P. 32—36.
9. Keenlyside R.A., Hierholzer J.C., D'Angelo L.J. Keratoconjunctivitis associated with adenovirus type 37: an extended outbreak in an ophthalmologist's office // J Infect Dis. 1983. № 147(2). P. 191—198.
10. Markova E.Yu. [Clinical features and treatment of inflammatory eye diseases in children] // Effective Рharmacotherapy. Pediatrics. 2010;(4):22—25. (In Russ.)
11. Murrah W.F. Epidemic keratoconjunctivitis // Ann Ophthalmol. 1988. № 20(1). P. 36—38.
12. Ozcan A.A., Ersoz T.R., Dulger E. Management of severe allergic conjunctivitis with topical cyclosporin a 0,05% eyedrops // Cornea. 2007. № 26. P. 1035—1038.
13. Darougar S., Hunter P.A., Viswalingam M., Gibson J.A., Jones B.R. Acute follicular conjunctivitis and keratoconjunctivitis in London // Br J Ophthalmol. 1978. № 62 (12). P. 843—849.
14. Doan S., Gabison E., Abitbol O. et al. Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunctivitis // J Fr Ophtalmol. 2007. № 30. P. 697—701.
15. Reinhard T., Godehardt E., Pfahl H.G., Sundmacher R. Local cyclosporine A in nummuli after keratoconjunctivitis epidemica. A pilot study // Ophthalmologe. 2000. № 97. P. 764—768.
16. Ryabtseva A.A., Tarannikova S.V. [The Ophtalmoferon experience in the clinical practice of ophthalmology]. Clinical study report. M.F. Vladimirskiy Moscow Reginal Research and Clinical Institute. — Moscow, 2011;5:24. (In Russ.)
17. Somova V.V., Nesterenko E.I., Shirokova N.V. [Epidemic Adenoviral Conjunctivitis. Modern treatment approaches]. Fedorovskie chteniya (Fedorov papers). — Moscow, 2009;(3):104—105. (In Russ.)
18. Maychuk Yu.F. [Extension of Ophtalmoferon use for treatment of various eye diseases] // Journal of Cataract and Refractive Surgery. 2012;(12):1:54—58. (In Russ.)
19. Yani E.V. [Evaluation of the clinical efficacy of Ophtalmoferon (eye drops) in the treatment of adenoviral eye diseases] // Novye Lekarstvennye Preparaty (New medications) 2006;(10):17—19. (In Russ.)
20. Egorov E.A. [Rational Pharmacotherapy in Ophthalmology: Guidelines for Practitioners]. Egorov E.A., Alekseev V.N., Yu.S. Astakhov Yu.S., Brzhevsky V.V., Brovkin A.F. et al. — Moscow: Litterra; 2004:954. (In Russ.)
21. Kasparov A.A. [Ophthalmic Herpes]. — Moscow: Meditsina Publ.; 1994. (In Russ.)
22. Krachmer J.H., Mannis M.J., Holland E.J. Fundamentals, diagnosis and management // Cornea. Elsevier Mosby. 2005;2:1005—1033.
23. Lyon D.B., Newman S.A. Secondary bacterial keratitis in herpes zoster ophthalmicus // Cornea. 1987;6(4):283—285.
24. Kasparova E.A. [Purulent corneal ulcers: etiology, pathogenesis, classification] // Vestnik Оftal'mologii (Annals of Ophtalmology). 2015; 131(5): 87—97. (In Russ.)
25. Ray M., Nigel L.C.S., Tan A.M. Triple infection keratitis // Eye Contact Lens. 2014;40(3):123—126.
26. Selinger D.S., Selinger R.C., Reed W.P. Resistance to infection of the external eye: the role of tears // Surv Ophthalmol. 1979; 24(1):33—38.
27. Wilhelmus K.R. The importance of having lysozyme // Cornea. 1985 1986;4(2):69—70.
28. Smolin G. The role of tears in the prevention of infections // Int Ophthalmol Clin. 1987;27(1): 25—26.
29. Evans D.J., Fleiszig S.M.J. Why does the healthy cornea resist Pseudomonas aeruginosa infection? // Am J Ophthalmol. 2013;155(6):961-970.e2.
30. Kumar A., Yu F-S.X. Toll-Like Receptors and Corneal Innate Immunity // Curr Mol Med. 2006;6(3):327—337.
31. Kasparov A.A. [Infectious inflammatory diseases of the outer part of the eye (the introduction to the discussion)] // Vestnik Oftal’mologii. (Annals of Ophtalmology)1987;103(1):61—62. (In Russ.)
32. Kumar A., Hazlett L.D., Yu F-S.X. Flagellin suppresses the inflammatory response and enhances bacterial clearance in a murine model of Pseudomonas aeruginosa keratitis // Infect Immun. 2008; 76(1):89—96.
33. Zhang X., Sun X., Wang Z., Zhang Y., Hou W. Keratitis-associated fungi form biofilms with reduced antifungal drug susceptibility // Invest Ophthalmol Vis Sci. 2012;53(12):7774—7778.
Review
For citations:
Markovа E.Yu., Pron'ko N.A., Venediktovа L.V. OCULAR MANIFESTATIONS OF VIRAL INFECTIONS IN CHILDREN. CHILDREN INFECTIONS. 2016;15(3):57-62. (In Russ.) https://doi.org/10.22627/2072-8107-2016-15-3-57-62
Views:
1252
Email this article 